{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:09:25Z","timestamp":1791803365721,"version":"4.3.4"},"reference-count":22,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2013,9,23]],"date-time":"2013-09-23T00:00:00Z","timestamp":1379894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Dermatology"],"published-print":{"date-parts":[[2014,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study explored the epidemiology, treatment, and comorbidities of juvenile psoriasis in Germany using health insurance data. Psoriasis is a chronic inflammatory skin condition that affects approximately 2% to 3% of the world's population. Data were obtained from a database of approximately 6.7 million individuals registered with health insurance organizations throughout Germany. The analysis considered all individuals age 18 years and younger with psoriasis who were registered in 2007. Comorbidities were identified using software based on a morbidity\u2010based risk adjustment model. A total of 138,338 patients with a diagnosis of psoriasis were identified in the database, yielding a prevalence of 2.1%. Within this group there were 4,499 children and adolescents (\u226418 years of age), a prevalence of 0.4%. The prevalence ranged from 0.1% at the age of 1 year to 0.8% at the age of 18 years. Most of the patients were treated with topical corticosteroids (72.2%) and antipsoriatics (e.g., tars, psoralen; 20.0%). Immunosuppressants were used in 3.3% of the cases. Juvenile psoriasis was associated with numerous significant comorbidities such as rheumatoid arthritis and inflammation (2.1%); delirium, psychosis, and psychotic and dissociative disorder (1.1%); and heart disease (0.6%). Our study demonstrated that psoriasis is more prevalent in children and adolescents than some older international investigations have documented. Analysis of the health insurance data showed that juvenile psoriasis is associated with a range of comorbidities. The data also may suggest an unrecognized burden of mental health problems in young persons with psoriasis.<\/jats:p>","DOI":"10.1111\/pde.12205","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T22:30:25Z","timestamp":1381530625000},"page":"8-13","source":"Crossref","is-referenced-by-count":40,"title":["Childhood Psoriasis\u2014An Analysis of German Health Insurance Data"],"prefix":"10.1111","volume":"31","author":[{"given":"David","family":"Matusiewicz","sequence":"first","affiliation":[{"name":"Institute for Health Care Management and Research University of Duisburg Essen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Koerber","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Hospital Essen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Schadendorf","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Hospital Essen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Wasem","sequence":"additional","affiliation":[{"name":"Institute for Health Care Management and Research University of Duisburg Essen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Neumann","sequence":"additional","affiliation":[{"name":"Institute for Health Care Management and Research University of Duisburg Essen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,9,23]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.12.1537"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-97931-6"},{"key":"e_1_2_7_4_1","volume-title":"Psoriasis. Prevalence, spontaneous course, and genetics. A census study on the prevalence of skin diseases on the Faroe Islands","author":"Lomholt G","year":"1963"},{"key":"e_1_2_7_5_1","first-page":"5","volume-title":"White book, dermatology in Europe","author":"Williams H","year":"2001"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e328305e24b"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-008-1664-2"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09276.x"},{"key":"e_1_2_7_9_1","first-page":"309","article-title":"Childhood psoriasis","volume":"64","author":"Farber EM","year":"1999","journal-title":"Cutis"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.paed.2007.07.004"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546630902911847"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09593.x"},{"key":"e_1_2_7_13_1","unstructured":"Federal Statistical Office.Statutory Health Insurance: Members Insured Persons. Table (ad\u2010hoc).http:\/\/www.gbe-bund.de Accessed July 5 2013."},{"key":"e_1_2_7_14_1","unstructured":"German Federal Health Insurance Authority (BVA; 2008). So funktioniert der neue Risikostrukturausgleich im Gesundheitsfonds.http:\/\/www.bundesversicherungsamt.de\/cln_108\/nn_1046668\/DE\/Risikostrukturausgleich\/Wie_funktioniert_Morbi_RSA templateId=raw property=publicationFile.pdf\/Wie_funktioniert_Morbi_RSA.pdfAccessed April 25 2013."},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8510(02)00114-8"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1252022"},{"key":"e_1_2_7_17_1","volume-title":"Children with psoriasis at risk of developing psychiatric disorders","author":"Brauser D","year":"2010"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000251595"},{"key":"e_1_2_7_19_1","volume-title":"Prevalence and health care situation of the juvenile psoriasis in Germany\u2014results from a secondary data analysis","author":"Kaempfe S","year":"2011"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.46.6.556"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-007-0145-9"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0770"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-012-2431-y"}],"container-title":["Pediatric Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpde.12205","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pde.12205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:17:13Z","timestamp":1696205833000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pde.12205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,23]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["10.1111\/pde.12205"],"URL":"https:\/\/doi.org\/10.1111\/pde.12205","archive":["Portico"],"relation":{},"ISSN":["0736-8046","1525-1470"],"issn-type":[{"value":"0736-8046","type":"print"},{"value":"1525-1470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,23]]}}}